RDTCF (Rapid Dose Therapeutics) OCF Margin %: 7.51% (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rapid Dose Therapeutics OCF Margin %?

Rapid Dose Therapeutics RDTCF OCF Margin % is 7.51% as of May. 2026. The stock has 4 warning signs investors should review. Among 957 Biotechnology companies, Rapid Dose Therapeutics ranks better than 71.89% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Rapid Dose Therapeutics's Cash Flow from Operations for the three months ended in May. 2026 was $0.03 Mil. Rapid Dose Therapeutics's Revenue for the three months ended in May. 2026 was $0.43 Mil. Therefore, Rapid Dose Therapeutics's OCF Margin % for the quarter that ended in May. 2026 was 7.51%.

As of today, Rapid Dose Therapeutics's current OCF Yield % is 0.93%.

The historical rank and industry rank for Rapid Dose Therapeutics's OCF Margin % or its related term are showing as below:

RDTCF' s OCF Margin % Range Over the Past 10 Years
Min: -3002.97   Med: -171.23   Max: -9.74
Current: 4.88

During the past 13 years, the highest OCF Margin % of Rapid Dose Therapeutics was -9.74%. The lowest was -3002.97%. And the median was -171.23%.

RDTCF's OCF Margin % is ranked better than
71.89% of 957 companies
in the Biotechnology industry
Industry Median: -70.9 vs RDTCF: 4.88

Rapid Dose Therapeutics OCF Margin % Related Terms

Rapid Dose Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics OCF Margin % Chart

Rapid Dose Therapeutics Annual Data
Trend Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.26 -120.22 -224.87 -55.01 -9.74

Rapid Dose Therapeutics Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.75 -38.93 -40.69 90.70 7.51

RDTCF vs VRTX, REGN, RVMD: OCF Margin % Comparison

For the Biotechnology subindustry, Rapid Dose Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's OCF Margin % falls into.


Rapid Dose Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Rapid Dose Therapeutics's OCF Margin for the fiscal year that ended in Feb. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Feb. 2026 )/Revenue (A: Feb. 2026 )
=-0.198/2.032
=-9.74 %

Rapid Dose Therapeutics's OCF Margin for the quarter that ended in May. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: May. 2026 )/Revenue (Q: May. 2026 )
=0.032/0.426
=7.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 7.51% mean?
Rapid Dose Therapeutics (RDTCF) has a OCF Margin % of 7.51% as of May. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rapid Dose Therapeutics and its competitors. According to the industry distribution chart, Rapid Dose Therapeutics ranks #269 out of 957 companies in the Biotechnology industry, placing it in the top 28.1%.
Is Rapid Dose Therapeutics' OCF Margin % too high?
Rapid Dose Therapeutics' current OCF Margin % is 7.51%. Based on the distribution chart, Rapid Dose Therapeutics ranks #269 out of 957 companies in the Biotechnology industry, which is above the industry midpoint.
How does Rapid Dose Therapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Rapid Dose Therapeutics ranks #269 out of 957 companies for OCF Margin %. This puts Rapid Dose Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current OCF Margin % is 7.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.20, compared to a current price of $0.09 — trading 57.5% below its estimated fair value. The current OCF Margin % is 7.51%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current OCF Margin % is 7.51% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.